Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group Article Swipe
Manuel Sánchez Cánovas
,
Miguel Ángel Moya Hernández
,
Evdochia Adoamnei
,
Diego Cacho Lavín
,
David Fernández Garay
,
T. Quintanar Verduguez
,
Jacobo Rogado
,
Francisco José García Verdejo
,
Silvia García Adrián
,
A. Pérez
,
María Esperanza Guirao García
,
Javier López Robles
,
Jaime Mendiola
,
Andrés J. Muñoz Martín
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s12094-024-03570-w
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s12094-024-03570-w
Purpose Both venous and arterial thrombotic events (VTE/AT) can be associated with Immune Checkpoint Inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice. Methods /Patients. This retrospective, multicenter study was promoted by the Thrombosis and Cancer Section of the Spanish Society of Medical Oncology (SEOM). Individuals with head and neck cancer who initiated ICI between 01/01/2015 and 31/12/2021 were recruited. Minimum follow-up was 6 months (except in cases of demise). The primary objective was to calculate the incidence of ICI-associated VTE/AT, with secondary objectives including the analysis of their impact on survival and the identification of variables predictive of VTE/AT. Results A total of 143 patients with head and neck cancer were enrolled. The incidence of VTE/AT during follow-up (median 8.6 months) was 2.8%. Survival analysis showed no significant differences (p = 0.644) between the group that developed VTE/AT (median 7.13 months, 95% CI 0–22.9) and the group that did not (median 9.86 months, 95% CI 6.3–13.4). The presence of liver metastases was predictive of VTE/AT (p < 0.05). Conclusions Thromboembolic disease associated with immunotherapy in patients with head and neck neoplasia does not significantly impact survival. The presence of liver metastases can predict these events.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s12094-024-03570-w
- https://link.springer.com/content/pdf/10.1007/s12094-024-03570-w.pdf
- OA Status
- hybrid
- Cited By
- 2
- References
- 13
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4399880289
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4399880289Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s12094-024-03570-wDigital Object Identifier
- Title
-
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer groupWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-06-21Full publication date if available
- Authors
-
Manuel Sánchez Cánovas, Miguel Ángel Moya Hernández, Evdochia Adoamnei, Diego Cacho Lavín, David Fernández Garay, T. Quintanar Verduguez, Jacobo Rogado, Francisco José García Verdejo, Silvia García Adrián, A. Pérez, María Esperanza Guirao García, Javier López Robles, Jaime Mendiola, Andrés J. Muñoz MartínList of authors in order
- Landing page
-
https://doi.org/10.1007/s12094-024-03570-wPublisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007/s12094-024-03570-w.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007/s12094-024-03570-w.pdfDirect OA link when available
- Concepts
-
Medicine, Cancer, Thrombosis, Head and neck, Head and neck cancer, Oncology, Internal medicine, SurgeryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2Per-year citation counts (last 5 years)
- References (count)
-
13Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4399880289 |
|---|---|
| doi | https://doi.org/10.1007/s12094-024-03570-w |
| ids.doi | https://doi.org/10.1007/s12094-024-03570-w |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38907096 |
| ids.openalex | https://openalex.org/W4399880289 |
| fwci | 2.53044777 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008297 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Male |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D012189 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Retrospective Studies |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D006258 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Head and Neck Neoplasms |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D005260 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Female |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D008875 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Middle Aged |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D000368 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Aged |
| mesh[7].qualifier_ui | Q000009 |
| mesh[7].descriptor_ui | D000082082 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | adverse effects |
| mesh[7].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D000082082 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[9].qualifier_ui | Q000453 |
| mesh[9].descriptor_ui | D013030 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | epidemiology |
| mesh[9].descriptor_name | Spain |
| mesh[10].qualifier_ui | Q000139 |
| mesh[10].descriptor_ui | D013927 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | chemically induced |
| mesh[10].descriptor_name | Thrombosis |
| mesh[11].qualifier_ui | Q000209 |
| mesh[11].descriptor_ui | D013927 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | etiology |
| mesh[11].descriptor_name | Thrombosis |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D015994 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Incidence |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000328 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Adult |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000369 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Aged, 80 and over |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D005500 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Follow-Up Studies |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D008495 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Medical Oncology |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D012955 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Societies, Medical |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | Q000009 |
| mesh[19].descriptor_ui | D000082082 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | adverse effects |
| mesh[19].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D006258 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Head and Neck Neoplasms |
| mesh[21].qualifier_ui | Q000401 |
| mesh[21].descriptor_ui | D006258 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | mortality |
| mesh[21].descriptor_name | Head and Neck Neoplasms |
| mesh[22].qualifier_ui | Q000473 |
| mesh[22].descriptor_ui | D006258 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | pathology |
| mesh[22].descriptor_name | Head and Neck Neoplasms |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D005260 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Female |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D008297 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Male |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D012189 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Retrospective Studies |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D008875 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Middle Aged |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000368 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Aged |
| mesh[28].qualifier_ui | Q000139 |
| mesh[28].descriptor_ui | D013927 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | chemically induced |
| mesh[28].descriptor_name | Thrombosis |
| mesh[29].qualifier_ui | Q000453 |
| mesh[29].descriptor_ui | D013927 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | epidemiology |
| mesh[29].descriptor_name | Thrombosis |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000328 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Adult |
| mesh[31].qualifier_ui | Q000453 |
| mesh[31].descriptor_ui | D013030 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | epidemiology |
| mesh[31].descriptor_name | Spain |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D015994 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Incidence |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D000369 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Aged, 80 and over |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D006801 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Humans |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D008297 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Male |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D012189 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Retrospective Studies |
| mesh[37].qualifier_ui | Q000188 |
| mesh[37].descriptor_ui | D006258 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | drug therapy |
| mesh[37].descriptor_name | Head and Neck Neoplasms |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D005260 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Female |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D008875 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Middle Aged |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D000368 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Aged |
| mesh[41].qualifier_ui | Q000009 |
| mesh[41].descriptor_ui | D000082082 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | adverse effects |
| mesh[41].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D000082082 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | Immune Checkpoint Inhibitors |
| mesh[43].qualifier_ui | Q000453 |
| mesh[43].descriptor_ui | D013030 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | epidemiology |
| mesh[43].descriptor_name | Spain |
| mesh[44].qualifier_ui | Q000139 |
| mesh[44].descriptor_ui | D013927 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | chemically induced |
| mesh[44].descriptor_name | Thrombosis |
| mesh[45].qualifier_ui | Q000209 |
| mesh[45].descriptor_ui | D013927 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | etiology |
| mesh[45].descriptor_name | Thrombosis |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D015994 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Incidence |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D000328 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Adult |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D000369 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Aged, 80 and over |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D005500 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Follow-Up Studies |
| type | article |
| title | Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group |
| biblio.issue | 1 |
| biblio.volume | 27 |
| biblio.last_page | 181 |
| biblio.first_page | 175 |
| topics[0].id | https://openalex.org/T10307 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9987000226974487 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2733 |
| topics[0].subfield.display_name | Otorhinolaryngology |
| topics[0].display_name | Head and Neck Cancer Studies |
| topics[1].id | https://openalex.org/T10417 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9973999857902527 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Lung Cancer Treatments and Mutations |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.996999979019165 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list.value | 3290 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4290 |
| apc_paid.value | 3290 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4290 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9676668643951416 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C121608353 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7320971488952637 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[1].display_name | Cancer |
| concepts[2].id | https://openalex.org/C2780868729 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6746373176574707 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q261327 |
| concepts[2].display_name | Thrombosis |
| concepts[3].id | https://openalex.org/C3018411727 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6317445039749146 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3867488 |
| concepts[3].display_name | Head and neck |
| concepts[4].id | https://openalex.org/C2776530083 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6250879764556885 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1783924 |
| concepts[4].display_name | Head and neck cancer |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.578738808631897 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5682515501976013 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C141071460 |
| concepts[7].level | 1 |
| concepts[7].score | 0.22830262780189514 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[7].display_name | Surgery |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9676668643951416 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/cancer |
| keywords[1].score | 0.7320971488952637 |
| keywords[1].display_name | Cancer |
| keywords[2].id | https://openalex.org/keywords/thrombosis |
| keywords[2].score | 0.6746373176574707 |
| keywords[2].display_name | Thrombosis |
| keywords[3].id | https://openalex.org/keywords/head-and-neck |
| keywords[3].score | 0.6317445039749146 |
| keywords[3].display_name | Head and neck |
| keywords[4].id | https://openalex.org/keywords/head-and-neck-cancer |
| keywords[4].score | 0.6250879764556885 |
| keywords[4].display_name | Head and neck cancer |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.578738808631897 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5682515501976013 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/surgery |
| keywords[7].score | 0.22830262780189514 |
| keywords[7].display_name | Surgery |
| language | en |
| locations[0].id | doi:10.1007/s12094-024-03570-w |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S179824187 |
| locations[0].source.issn | 1699-048X, 1699-3055 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1699-048X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Clinical & Translational Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007/s12094-024-03570-w.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical and Translational Oncology |
| locations[0].landing_page_url | https://doi.org/10.1007/s12094-024-03570-w |
| locations[1].id | pmid:38907096 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38907096 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11735473 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Clin Transl Oncol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11735473 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5060670657 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-8687-4101 |
| authorships[0].author.display_name | Manuel Sánchez Cánovas |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210144034 |
| authorships[0].affiliations[0].raw_affiliation_string | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4210144034 |
| authorships[0].institutions[0].ror | https://ror.org/0532s5p48 |
| authorships[0].institutions[0].type | other |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210144034 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Spanish Society of Hematology and Hemotherapy |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Manuel Sánchez Cánovas |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[1].author.id | https://openalex.org/A5102692393 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Miguel Ángel Moya Hernández |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210091031 |
| authorships[1].affiliations[0].raw_affiliation_string | Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain |
| authorships[1].institutions[0].id | https://openalex.org/I4210091031 |
| authorships[1].institutions[0].ror | https://ror.org/00cfm3y81 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210091031 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Hospital General Universitario Morales Meseguer |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Miguel Ángel Moya Hernández |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain |
| authorships[2].author.id | https://openalex.org/A5006247544 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3633-2245 |
| authorships[2].author.display_name | Evdochia Adoamnei |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I80180929 |
| authorships[2].affiliations[0].raw_affiliation_string | Nursing Department, Nursing Faculty, University of Murcia, IMIB-Arrixaca, Murcia, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I80180929 |
| authorships[2].institutions[0].ror | https://ror.org/03p3aeb86 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I80180929 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Universidad de Murcia |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Evdochia Adoamnei |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Nursing Department, Nursing Faculty, University of Murcia, IMIB-Arrixaca, Murcia, Spain |
| authorships[3].author.id | https://openalex.org/A5016903080 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Diego Cacho Lavín |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210144034 |
| authorships[3].affiliations[0].raw_affiliation_string | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I4210144034 |
| authorships[3].institutions[0].ror | https://ror.org/0532s5p48 |
| authorships[3].institutions[0].type | other |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210144034 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Spanish Society of Hematology and Hemotherapy |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Diego Cacho Lavin |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[4].author.id | https://openalex.org/A5025555281 |
| authorships[4].author.orcid | https://orcid.org/0009-0006-4789-5384 |
| authorships[4].author.display_name | David Fernández Garay |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210144034 |
| authorships[4].affiliations[0].raw_affiliation_string | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[4].institutions[0].id | https://openalex.org/I4210144034 |
| authorships[4].institutions[0].ror | https://ror.org/0532s5p48 |
| authorships[4].institutions[0].type | other |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210144034 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Spanish Society of Hematology and Hemotherapy |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | David Fernández Garay |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[5].author.id | https://openalex.org/A5026211992 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | T. Quintanar Verduguez |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210144034 |
| authorships[5].affiliations[0].raw_affiliation_string | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[5].institutions[0].id | https://openalex.org/I4210144034 |
| authorships[5].institutions[0].ror | https://ror.org/0532s5p48 |
| authorships[5].institutions[0].type | other |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210144034 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Spanish Society of Hematology and Hemotherapy |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Teresa Quintanar Verdúguez |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[6].author.id | https://openalex.org/A5088145681 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9795-8762 |
| authorships[6].author.display_name | Jacobo Rogado |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210165557 |
| authorships[6].affiliations[0].raw_affiliation_string | Medical Oncology Department, Hospital Universitario Infanta Leonor, Madrid, Spain |
| authorships[6].institutions[0].id | https://openalex.org/I4210165557 |
| authorships[6].institutions[0].ror | https://ror.org/05nfzf209 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210139293, https://openalex.org/I4210165557 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Hospital Universitario Infanta Leonor |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Jacobo Rogado Revuelta |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Medical Oncology Department, Hospital Universitario Infanta Leonor, Madrid, Spain |
| authorships[7].author.id | https://openalex.org/A5006862278 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Francisco José García Verdejo |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210117781 |
| authorships[7].affiliations[0].raw_affiliation_string | Medical Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain |
| authorships[7].institutions[0].id | https://openalex.org/I4210117781 |
| authorships[7].institutions[0].ror | https://ror.org/02ecxgj38 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I158283456, https://openalex.org/I4210117781 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Complejo Hospitalario de Jaén |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Francisco José García Verdejo |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Medical Oncology Department, Complejo Hospitalario de Jaén, Jaén, Spain |
| authorships[8].author.id | https://openalex.org/A5052693890 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-3211-4016 |
| authorships[8].author.display_name | Silvia García Adrián |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210144034 |
| authorships[8].affiliations[0].raw_affiliation_string | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210144034 |
| authorships[8].institutions[0].ror | https://ror.org/0532s5p48 |
| authorships[8].institutions[0].type | other |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210144034 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Spanish Society of Hematology and Hemotherapy |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Silvia García Adrián |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[9].author.id | https://openalex.org/A5073275543 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0464-5976 |
| authorships[9].author.display_name | A. Pérez |
| authorships[9].countries | ES |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210144034 |
| authorships[9].affiliations[0].raw_affiliation_string | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[9].institutions[0].id | https://openalex.org/I4210144034 |
| authorships[9].institutions[0].ror | https://ror.org/0532s5p48 |
| authorships[9].institutions[0].type | other |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210144034 |
| authorships[9].institutions[0].country_code | ES |
| authorships[9].institutions[0].display_name | Spanish Society of Hematology and Hemotherapy |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Ana Isabel Ferrer Pérez |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[10].author.id | https://openalex.org/A5111273190 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | María Esperanza Guirao García |
| authorships[10].countries | ES |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210091031 |
| authorships[10].affiliations[0].raw_affiliation_string | Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain |
| authorships[10].institutions[0].id | https://openalex.org/I4210091031 |
| authorships[10].institutions[0].ror | https://ror.org/00cfm3y81 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210091031 |
| authorships[10].institutions[0].country_code | ES |
| authorships[10].institutions[0].display_name | Hospital General Universitario Morales Meseguer |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | María Esperanza Guirao García |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain |
| authorships[11].author.id | https://openalex.org/A5103124413 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5353-1847 |
| authorships[11].author.display_name | Javier López Robles |
| authorships[11].countries | ES |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210091031 |
| authorships[11].affiliations[0].raw_affiliation_string | Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain |
| authorships[11].institutions[0].id | https://openalex.org/I4210091031 |
| authorships[11].institutions[0].ror | https://ror.org/00cfm3y81 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210091031 |
| authorships[11].institutions[0].country_code | ES |
| authorships[11].institutions[0].display_name | Hospital General Universitario Morales Meseguer |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Javier López Robles |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain |
| authorships[12].author.id | https://openalex.org/A5073309867 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-0657-9346 |
| authorships[12].author.display_name | Jaime Mendiola |
| authorships[12].countries | ES |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210154894, https://openalex.org/I80180929 |
| authorships[12].affiliations[0].raw_affiliation_string | School of Medicine, Social and Health Sciences, University of Murcia, IMIB-Arrixaca, Cyber Epidemiology and Public Health (CIBERESP), Murcia, Spain |
| authorships[12].institutions[0].id | https://openalex.org/I4210154894 |
| authorships[12].institutions[0].ror | https://ror.org/050q0kv47 |
| authorships[12].institutions[0].type | facility |
| authorships[12].institutions[0].lineage | https://openalex.org/I2801357902, https://openalex.org/I4210115082, https://openalex.org/I4210154894, https://openalex.org/I4387152914 |
| authorships[12].institutions[0].country_code | ES |
| authorships[12].institutions[0].display_name | Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública |
| authorships[12].institutions[1].id | https://openalex.org/I80180929 |
| authorships[12].institutions[1].ror | https://ror.org/03p3aeb86 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I80180929 |
| authorships[12].institutions[1].country_code | ES |
| authorships[12].institutions[1].display_name | Universidad de Murcia |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Jaime Mendiola |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | School of Medicine, Social and Health Sciences, University of Murcia, IMIB-Arrixaca, Cyber Epidemiology and Public Health (CIBERESP), Murcia, Spain |
| authorships[13].author.id | https://openalex.org/A5042384932 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-6977-8249 |
| authorships[13].author.display_name | Andrés J. Muñoz Martín |
| authorships[13].countries | ES |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210144034 |
| authorships[13].affiliations[0].raw_affiliation_string | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| authorships[13].institutions[0].id | https://openalex.org/I4210144034 |
| authorships[13].institutions[0].ror | https://ror.org/0532s5p48 |
| authorships[13].institutions[0].type | other |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210144034 |
| authorships[13].institutions[0].country_code | ES |
| authorships[13].institutions[0].display_name | Spanish Society of Hematology and Hemotherapy |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Andrés J. Muñoz Martín |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Spanish Society of Medical Oncology (SEOM) Thrombosis and Cancer Group, Madrid, Spain |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007/s12094-024-03570-w.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10307 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9987000226974487 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2733 |
| primary_topic.subfield.display_name | Otorhinolaryngology |
| primary_topic.display_name | Head and Neck Cancer Studies |
| related_works | https://openalex.org/W2186113122, https://openalex.org/W1523310174, https://openalex.org/W2531913951, https://openalex.org/W4302381976, https://openalex.org/W4243634448, https://openalex.org/W2946105426, https://openalex.org/W2020999744, https://openalex.org/W4393095456, https://openalex.org/W1980398461, https://openalex.org/W1991628107 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s12094-024-03570-w |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S179824187 |
| best_oa_location.source.issn | 1699-048X, 1699-3055 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1699-048X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Clinical & Translational Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s12094-024-03570-w.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical and Translational Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s12094-024-03570-w |
| primary_location.id | doi:10.1007/s12094-024-03570-w |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S179824187 |
| primary_location.source.issn | 1699-048X, 1699-3055 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1699-048X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Clinical & Translational Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s12094-024-03570-w.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical and Translational Oncology |
| primary_location.landing_page_url | https://doi.org/10.1007/s12094-024-03570-w |
| publication_date | 2024-06-21 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4281787256, https://openalex.org/W4363645055, https://openalex.org/W4323312776, https://openalex.org/W3030798067, https://openalex.org/W2949230556, https://openalex.org/W4391682094, https://openalex.org/W4388852093, https://openalex.org/W2529484692, https://openalex.org/W3186670804, https://openalex.org/W4200247705, https://openalex.org/W3132560673, https://openalex.org/W4210670182, https://openalex.org/W2108836663 |
| referenced_works_count | 13 |
| abstract_inverted_index.6 | 70 |
| abstract_inverted_index.= | 138 |
| abstract_inverted_index.A | 108 |
| abstract_inverted_index.a | 20 |
| abstract_inverted_index.(p | 137, 173 |
| abstract_inverted_index.CI | 150, 162 |
| abstract_inverted_index.be | 10 |
| abstract_inverted_index.by | 38 |
| abstract_inverted_index.in | 26, 73, 182 |
| abstract_inverted_index.is | 19 |
| abstract_inverted_index.no | 134 |
| abstract_inverted_index.of | 22, 44, 48, 75, 85, 94, 102, 105, 110, 122, 166, 171, 196 |
| abstract_inverted_index.on | 97 |
| abstract_inverted_index.to | 81 |
| abstract_inverted_index.143 | 111 |
| abstract_inverted_index.8.6 | 127 |
| abstract_inverted_index.95% | 149, 161 |
| abstract_inverted_index.ICI | 60 |
| abstract_inverted_index.The | 77, 120, 164, 194 |
| abstract_inverted_index.and | 4, 41, 55, 63, 99, 115, 152, 186 |
| abstract_inverted_index.can | 9, 199 |
| abstract_inverted_index.did | 156 |
| abstract_inverted_index.not | 157, 190 |
| abstract_inverted_index.the | 39, 45, 83, 92, 100, 141, 153 |
| abstract_inverted_index.was | 36, 69, 80, 129, 169 |
| abstract_inverted_index.who | 58 |
| abstract_inverted_index.< | 174 |
| abstract_inverted_index.7.13 | 147 |
| abstract_inverted_index.9.86 | 159 |
| abstract_inverted_index.Both | 2 |
| abstract_inverted_index.This | 32 |
| abstract_inverted_index.does | 189 |
| abstract_inverted_index.head | 54, 114, 185 |
| abstract_inverted_index.neck | 56, 116, 187 |
| abstract_inverted_index.that | 143, 155 |
| abstract_inverted_index.were | 65, 118 |
| abstract_inverted_index.with | 12, 53, 88, 113, 180, 184 |
| abstract_inverted_index.2.8%. | 130 |
| abstract_inverted_index.cases | 74 |
| abstract_inverted_index.group | 142, 154 |
| abstract_inverted_index.liver | 167, 197 |
| abstract_inverted_index.study | 35 |
| abstract_inverted_index.their | 95 |
| abstract_inverted_index.there | 18 |
| abstract_inverted_index.these | 201 |
| abstract_inverted_index.total | 109 |
| abstract_inverted_index.(ICI). | 16 |
| abstract_inverted_index.0.05). | 175 |
| abstract_inverted_index.0.644) | 139 |
| abstract_inverted_index.Cancer | 42 |
| abstract_inverted_index.Immune | 13 |
| abstract_inverted_index.VTE/AT | 123, 145, 172 |
| abstract_inverted_index.cancer | 57, 117 |
| abstract_inverted_index.during | 124 |
| abstract_inverted_index.events | 7 |
| abstract_inverted_index.impact | 96, 192 |
| abstract_inverted_index.months | 71 |
| abstract_inverted_index.showed | 133 |
| abstract_inverted_index.venous | 3 |
| abstract_inverted_index.(SEOM). | 51 |
| abstract_inverted_index.(except | 72 |
| abstract_inverted_index.(median | 126, 146, 158 |
| abstract_inverted_index.Medical | 49 |
| abstract_inverted_index.Methods | 30 |
| abstract_inverted_index.Minimum | 67 |
| abstract_inverted_index.Purpose | 1 |
| abstract_inverted_index.Results | 107 |
| abstract_inverted_index.Section | 43 |
| abstract_inverted_index.Society | 47 |
| abstract_inverted_index.Spanish | 46 |
| abstract_inverted_index.VTE/AT, | 87 |
| abstract_inverted_index.VTE/AT. | 106 |
| abstract_inverted_index.apropos | 24 |
| abstract_inverted_index.between | 61, 140 |
| abstract_inverted_index.disease | 178 |
| abstract_inverted_index.events. | 202 |
| abstract_inverted_index.months) | 128 |
| abstract_inverted_index.months, | 148, 160 |
| abstract_inverted_index.paucity | 21 |
| abstract_inverted_index.predict | 200 |
| abstract_inverted_index.primary | 78 |
| abstract_inverted_index.routine | 27 |
| abstract_inverted_index.(VTE/AT) | 8 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 17 |
| abstract_inverted_index.Oncology | 50 |
| abstract_inverted_index.Survival | 131 |
| abstract_inverted_index.analysis | 93, 132 |
| abstract_inverted_index.arterial | 5 |
| abstract_inverted_index.clinical | 28 |
| abstract_inverted_index.demise). | 76 |
| abstract_inverted_index.patients | 25, 112, 183 |
| abstract_inverted_index.presence | 165, 195 |
| abstract_inverted_index.promoted | 37 |
| abstract_inverted_index.survival | 98 |
| abstract_inverted_index.0–22.9) | 151 |
| abstract_inverted_index.calculate | 82 |
| abstract_inverted_index.developed | 144 |
| abstract_inverted_index.enrolled. | 119 |
| abstract_inverted_index.follow-up | 68, 125 |
| abstract_inverted_index.incidence | 84, 121 |
| abstract_inverted_index.including | 91 |
| abstract_inverted_index.initiated | 59 |
| abstract_inverted_index.neoplasia | 188 |
| abstract_inverted_index.objective | 79 |
| abstract_inverted_index.practice. | 29 |
| abstract_inverted_index.secondary | 89 |
| abstract_inverted_index.survival. | 193 |
| abstract_inverted_index.variables | 103 |
| abstract_inverted_index./Patients. | 31 |
| abstract_inverted_index.01/01/2015 | 62 |
| abstract_inverted_index.31/12/2021 | 64 |
| abstract_inverted_index.Checkpoint | 14 |
| abstract_inverted_index.Inhibitors | 15 |
| abstract_inverted_index.Thrombosis | 40 |
| abstract_inverted_index.associated | 11, 179 |
| abstract_inverted_index.metastases | 168, 198 |
| abstract_inverted_index.objectives | 90 |
| abstract_inverted_index.predictive | 104, 170 |
| abstract_inverted_index.recruited. | 66 |
| abstract_inverted_index.thrombotic | 6 |
| abstract_inverted_index.Conclusions | 176 |
| abstract_inverted_index.Individuals | 52 |
| abstract_inverted_index.differences | 136 |
| abstract_inverted_index.information | 23 |
| abstract_inverted_index.multicenter | 34 |
| abstract_inverted_index.significant | 135 |
| abstract_inverted_index.6.3–13.4). | 163 |
| abstract_inverted_index.immunotherapy | 181 |
| abstract_inverted_index.significantly | 191 |
| abstract_inverted_index.ICI-associated | 86 |
| abstract_inverted_index.Thromboembolic | 177 |
| abstract_inverted_index.identification | 101 |
| abstract_inverted_index.retrospective, | 33 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 95 |
| corresponding_author_ids | https://openalex.org/A5060670657 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 14 |
| corresponding_institution_ids | https://openalex.org/I4210144034 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7699999809265137 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.81614607 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |